Literature DB >> 8110442

Assessing depression in schizophrenia: the Calgary Depression Scale.

D Addington1, J Addington, E Maticka-Tyndale.   

Abstract

Since existing depression scales were designed for assessment of depression in non-psychotic populations, such scales have items which do not distinguish depressed from non-depressed psychotic subjects. The authors describe a new scale, the Calgary Depression Scale, which was designed for the assessment of depression in schizophrenia. The scale was derived from two existing scales by factor analysis and reliability analysis. It has been further tested in two new samples. In the first it has been shown to be reliable, congruent with a self-report scale and valid. In the second sample it has been shown that there is no overlap with negative or extrapyramidal symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8110442

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  277 in total

Review 1.  Instruments measuring behavioral disturbance in relatives with schizophrenia.

Authors:  H L Provencher; J P Fournier; M Perreault; J Vezina
Journal:  Community Ment Health J       Date:  2000-06

2.  Pimozide augmentation in a patient with drug-resistant psychosis previously treated with olanzapine.

Authors:  J Takhar
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

3.  The interrelation of needs and quality of life in first-episode schizophrenia.

Authors:  Karin Landolt; Wulf Rössler; Tom Burns; Vladeta Ajdacic-Gross; Silvana Galderisi; Jan Libiger; Dieter Naber; Eske M Derks; René S Kahn; W Wolfgang Fleischhacker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-24       Impact factor: 5.270

4.  Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response.

Authors:  John Kasckow; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Thomas Meeks; Sidney Zisook
Journal:  Am J Geriatr Psychiatry       Date:  2010-09       Impact factor: 4.105

5.  Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis.

Authors:  Jacqueline Stowkowy; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2011-09-23       Impact factor: 2.732

6.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

7.  How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?

Authors:  Pierre Michel; Pascal Auquier; Karine Baumstarck; Anderson Loundou; Badih Ghattas; Christophe Lançon; Laurent Boyer
Journal:  Qual Life Res       Date:  2015-04-09       Impact factor: 4.147

Review 8.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

9.  Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.

Authors:  Jean Addington; Hely Shah; Lu Liu; Donald Addington
Journal:  Schizophr Res       Date:  2014-01-16       Impact factor: 4.939

10.  Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.

Authors:  G Fond; M Faugere; C Faget-Agius; M Cermolacce; R Richieri; L Boyer; C Lançon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-08-04       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.